Ono Pharmaceutical Co Stock Investor Sentiment

OPHLY Stock  USD 3.59  0.09  2.45%   
Slightly above 61% of Ono Pharmaceutical's investor base is looking to short. The analysis of overall sentiment of trading Ono Pharmaceutical Co pink sheet suggests that many investors are alarmed at this time. Ono Pharmaceutical's investing sentiment can be driven by a variety of factors including economic data, Ono Pharmaceutical's earnings reports, geopolitical events, and overall market trends.
  
over six months ago at news.google.com         
Ono Pharmaceutical GAAP EPS of 229.06, revenue of 389.91B - Seeking Alpha
Google News at Macroaxis
over six months ago at news.google.com         
Sandoz to Introduce Biosimilar for Multiple Sclerosis Drug in Germany - Marketscreener.com
Google News at Macroaxis
over six months ago at news.google.com         
Taro Pharmaceutical to go Private in Merger Deal With Sun Pharmaceutical - Marketscreener.com
Google News at Macroaxis
over six months ago at news.google.com         
Vistin Pharma ASA Announces Cash Dividend, Payable on or About 30 January 2024 - Marketscreener.com
Google News at Macroaxis
over six months ago at news.google.com         
Ono and EVQLV partner to develop new antibody drugs - Pharmaceutical Technology
Google News at Macroaxis
over six months ago at news.google.com         
Strides Pharma Science Subsidiary Secures Credit Facility Worth INR319 Million - Marketscreener.com
Google News at Macroaxis
over six months ago at news.google.com         
The BioMed X Institute -December 19, 2023 at 0446 am EST - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Sector Update Health Care Stocks Advance Tuesday Afternoon - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Bafna Pharmaceuticals Resumes Commercial Production of Manufacturing Units in Chennai, India - Marke...
Google News at Macroaxis
over a year ago at news.google.com         
Sun Pharmaceutical HR Head to Retire Successor Named - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Ono Expands Investment in Ono Venture Investment Fund I, L.P. to ... - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
How to Safeguard Your Portfolio With Recession-Resistant Stocks ... - Investing.com
Google News at Macroaxis
over a year ago at news.google.com         
FATE Q3 Earnings Beat on Lower Expenses, Revenues Fall YY - msnNOW
Google News at Macroaxis
over a year ago at news.google.com         
Fate Therapeutics Reports Third Quarter 2023 Financial Results and ... - GlobeNewswire
Google News at Macroaxis
over a year ago at news.google.com         
Daily Brief Health Care WuXi XDC Cayman , CMIC Holdings, TSE ... - Smartkarma
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Ono Pharmaceutical that are available to investors today. That information is available publicly through Ono media outlets and privately through word of mouth or via Ono internal channels. However, regardless of the origin, that massive amount of Ono data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ono Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ono Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ono Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ono Pharmaceutical alpha.

Ono Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for Ono Pink Sheet Analysis

When running Ono Pharmaceutical's price analysis, check to measure Ono Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ono Pharmaceutical is operating at the current time. Most of Ono Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Ono Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ono Pharmaceutical's price. Additionally, you may evaluate how the addition of Ono Pharmaceutical to your portfolios can decrease your overall portfolio volatility.